Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
45.23B | 43.73B | 50.20B | 45.52B | 37.55B | 30.37B | Gross Profit |
13.67B | 12.53B | 15.53B | 14.37B | 11.93B | 8.49B | EBIT |
3.97B | 3.02B | 6.13B | 5.60B | 4.08B | 1.91B | EBITDA |
6.02B | 5.04B | 7.97B | 7.15B | 5.71B | 3.38B | Net Income Common Stockholders |
2.71B | 2.02B | 4.56B | 4.03B | 2.89B | 1.46B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.21B | 16.40B | 11.89B | 12.65B | 12.33B | 4.92B | Total Assets |
67.64B | 66.80B | 60.16B | 55.10B | 47.51B | 35.05B | Total Debt |
8.88B | 11.82B | 9.36B | 6.38B | 5.48B | 10.25B | Net Debt |
-833.00M | -2.90B | -2.53B | -2.27B | -1.85B | 5.33B | Total Liabilities |
27.53B | 26.24B | 30.19B | 30.24B | 27.18B | 19.97B | Stockholders Equity |
40.11B | 40.56B | 29.98B | 24.86B | 20.33B | 15.08B |
Cash Flow | Free Cash Flow | ||||
0.00 | -5.92B | -2.09B | -486.00M | 10.50B | 5.07B | Operating Cash Flow |
0.00 | -2.11B | 929.00M | 2.68B | 11.67B | 5.92B | Investing Cash Flow |
0.00 | -5.09B | -3.63B | -3.08B | -1.55B | -919.00M | Financing Cash Flow |
0.00 | 10.49B | 1.24B | 406.00M | -3.15B | -3.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥26.08B | 6.80 | 3.75% | 7.43% | 18.47% | ||
76 Outperform | ¥28.35B | 11.96 | 4.47% | 4.40% | 18.83% | ||
74 Outperform | ¥5.70B | 13.22 | 4.08% | 0.20% | -40.38% | ||
72 Outperform | ¥26.53B | 12.15 | 4.03% | -12.88% | -69.11% | ||
69 Neutral | ¥11.45B | 19.43 | 2.57% | -10.39% | -43.57% | ||
69 Neutral | ¥9.58B | 10.92 | 0.55% | 9.79% | -25.96% | ||
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% |